This investment vehicle's primary objective is to track the overall performance, measured by total return, of the NASDAQ Junior Biotechnology Index, before accounting for any associated fees or expenses. The index itself is a rule-based compilation of U. S.-listed small-capitalization ("junior") biotechnology companies, carefully selected from the broader spectrum of businesses found within the NASDAQ Biotechnology Index.